Treatment-related microangiopathic glomerulopathy and severe chronic kidney disease (CKD) in recurrent epithelial ovarian cancer (rEOC): A possible relationship with pegylated liposomal doxorubicin (PLD).

Maryann Kwa,R.A. Baumgartner,Linda Shavit,I. Barash,J. Michael,Igor Puzanov,J. Kopolovic,Ora Rosengarten,A. Hung,H. Jones,Alberto Gabizon,Franco M. Muggia

Treatment-related microangiopathic glomerulopathy and severe chronic kidney disease (CKD) in recurrent epithelial ovarian cancer (rEOC): A possible relationship with pegylated liposomal doxorubicin (PLD).

2011

Maryann Kwa
R.A. Baumgartner
Linda Shavit
I. Barash
J. Michael
Igor Puzanov
J. Kopolovic
Ora Rosengarten
A. Hung
H. Jones
Alberto Gabizon
Franco M. Muggia

e15551 Background: Treatment-related CKD and hypertension (HTN) are emerging as problems in patients receiving multiple treatments for recurrent epithelial ovarian cancer (rEOC). Methods: 8 patient...

Keywords:

Pegylated Liposomal Doxorubicin
Ovarian cancer
Oncology
Pathology
Kidney disease
Immunology
Internal medicine
Diabetes mellitus
Glomerulopathy
Medicine
epithelial ovarian cancer
Multiple treatments
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations